Construction and characterization of rhesus monkey rotavirus (MMU18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines

By Hoshino Y.   Jones R.W.   Ross J.   Kapikian A.Z.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 3003-3010

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

By Clements-Mann M.L.   Makhene M.K.   Mrukowicz J.   Wright P.F.   Hoshino Y.   Midthun K.   Sperber E.   Karron R.   Kapikian A.Z.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2715-2725

Elsevier

Access to resources Recommend Favorite

Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

By Lanata C.F.   Black R.E.   Flores J.   Lazo F.   Butron B.   Linares A.   Huapaya A.   Ventura G.   Gil A.   Kapikian A.Z.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite

Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4

By Ijaz M.K.   Nur-E-Kamal M.S.A.   Dar F.K.   Uduman S.   Redmond M.J.   Attah-Poku S.K.   Dent D.   Babiuk L.A.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 916-920

Elsevier

Access to resources Recommend Favorite

Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4

By Ijaz M.K.   Alkarmi T.O.   El-Mekki A.W.   Galadari S.H.I.   Dar F.K.   Babiuk L.A.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 331-338

Elsevier

Access to resources Recommend Favorite